Scioderm, Inc. Receives Positive Opinion From European Orphan Medicinal

Scioderm, Inc. receives Positive Opinion from European Orphan Medicinal
17, 2013 — DURHAM, N.C., Dec. 17, 2013 /PRNewswire/ — Scioderm, Inc., today announced that the Committee for Orphan Medicinal Products (COMP) issued a positive opinion on the application for orphan designation for SD-101 for the treatment of patients … Read more on Sacramento Bee

Personal genetic tests face sharper scrutiny after 23andMe
Increased regulation is needed to make sure tests like 23andMe's fulfill their claims, said James Evans, a geneticist at the University of North Carolina in Chapel Hill. "These tests should ultimately have to prove themselves," Evans said in a … Read more on Stanly News & Press

Attorneys General Ask FDA to Rethink Zohydro ER Approval
"Law enforcement officers, public health workers, and substance abuse treatment providers are just now beginning to stem the tide of prescription drug addiction. … to the FDA are attorneys general from Alaska, Arizona, Arkansas, Connecticut, Delaware … Read more on Medscape

Alabama Voices: Prisons ripe for reforms
By adopting policies based on conservative principles — personal responsibility, fiscal discipline, and individual liberty — states including Georgia, North Carolina and Texas have enacted policies proven to both enhance public safety and minimize … Read more on Montgomery Advertiser